Of the 212,944 patients with cancer and available CDH1 sequencing data, 151,465 had breast cancer (71.1%), 27,915 had CRC (13.1%), 15,225 had ovarian cancer (7.1%), and 18,339 (8.6%) had other cancer types (Fig. 1a and Table 1). This evidence concerns the gene CDH1 and ovarian cancer.